Literature DB >> 26163264

miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma.

Suling Chen1, Fang Li2, Haiyun Chai2, Xin Tao2, Haili Wang3, Aifang Ji4.   

Abstract

MicroRNAs (miRNAs) play a key role in carcinogenesis and tumor progression in hepatocellular carcinoma (HCC). In the present study, we demonstrated that miR-502 significantly inhibits HCC cell proliferation in vitro and tumor growth in vivo. G1/S cell cycle arrest and apoptosis of HCC cells were induced by miR-502. Phosphoinositide 3-kinase catalytic subunit gamma (PIK3CG) was identified as a direct downstream target of miR-502 in HCC cells. Notably, overexpression of PIK3CG reversed the inhibitory effects of miR-502 in HCC cells. Our findings suggest that miR-502 functions as a tumor suppressor in HCC via inhibition of PI3KCG, supporting its utility as a promising therapeutic gene target for this tumor type.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; PIK3CG; Proliferation; miR-502

Mesh:

Substances:

Year:  2015        PMID: 26163264     DOI: 10.1016/j.bbrc.2015.06.168

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.

Authors:  Jingjing Tian; Xibao Hu; Wei Gao; Jie Zhang; Ming Chen; Xinrong Zhang; Junhong Ma; Hongxia Yuan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  miR-502-5p affects gastric cancer progression by targeting PD-L1.

Authors:  Wendao You; Xiaoyu Liu; Yang Yu; Chen Chen; Yujia Xiong; Yiting Liu; Yibin Sun; Chenhuan Tan; Hanshuo Zhang; Yadong Wang; Rui Li
Journal:  Cancer Cell Int       Date:  2020-08-15       Impact factor: 5.722

3.  Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin-induced cardiotoxicity.

Authors:  Amelie Beaumier; Sally R Robinson; Nicholas Robinson; Katherine E Lopez; Dawn M Meola; Lisa G Barber; Barret J Bulmer; Jerome Calvalido; John E Rush; Ashish Yeri; Saumya Das; Vicky K Yang
Journal:  J Vet Intern Med       Date:  2020-04-07       Impact factor: 3.333

4.  Overexpression of PIK3R1 promotes hepatocellular carcinoma progression.

Authors:  Xuejun Ai; Lei Xiang; Zhi Huang; Shi Zhou; Shuai Zhang; Tao Zhang; Tianpeng Jiang
Journal:  Biol Res       Date:  2018-11-29       Impact factor: 5.612

5.  Differential miRNA Expression in Human Macrophage-Like Cells Infected with Histoplasma capsulatum Yeasts Cultured in Planktonic and Biofilm Forms.

Authors:  Nayla de Souza Pitangui; Junya de Lacorte Singulani; Janaina de Cássia Orlandi Sardi; Paula Carolina de Souza; Gabriela Rodríguez-Arellanes; Blanca Estela García-Pérez; Francisco Javier Enguita; Fernando R Pavan; Maria Lucia Taylor; Maria José Soares Mendes-Giannini; Ana Marisa Fusco-Almeida
Journal:  J Fungi (Basel)       Date:  2021-01-18

6.  Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma.

Authors:  Chuanli Zeng; Gang Yuan; Yaoren Hu; Donghui Wang; Xiaojun Shi; Dedong Zhu; Airong Hu; Yina Meng; Jialin Lu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

7.  LncRNA LINC00473 is involved in the progression of invasive pituitary adenoma by upregulating KMT5A via ceRNA-mediated miR-502-3p evasion.

Authors:  Junjun Li; Yuan Qian; Chao Zhang; Wei Wang; Yisheng Qiao; Hao Song; Liyan Li; Jiazhi Guo; Di Lu; Xingli Deng
Journal:  Cell Death Dis       Date:  2021-06-05       Impact factor: 8.469

8.  Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.

Authors:  Kai Hung Tiong; Boon Shing Tan; Heng Lungh Choo; Felicia Fei-Lei Chung; Ling-Wei Hii; Si Hoey Tan; Nelson Tze Woei Khor; Shew Fung Wong; Sze-Jia See; Yuen-Fen Tan; Rozita Rosli; Soon-Keng Cheong; Chee-Onn Leong
Journal:  Oncotarget       Date:  2016-09-06

9.  CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.

Authors:  Yufan Ying; Jiangfeng Li; Haiyun Xie; Huaqing Yan; Ke Jin; Liujia He; Xueyou Ma; Jian Wu; Xin Xu; Jiajie Fang; Xiao Wang; Xiangyi Zheng; Ben Liu; Liping Xie
Journal:  Cell Prolif       Date:  2020-01-23       Impact factor: 6.831

10.  MiR-502 is the first reported miRNA simultaneously targeting two components of the classical non-homologous end joining (C-NHEJ) in pancreatic cell lines.

Authors:  Agnieszka Smolinska; Julia Swoboda; Wojciech Fendler; Markus M Lerch; Matthias Sendler; Patryk Moskwa
Journal:  Heliyon       Date:  2020-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.